10x Genomics, Inc. Class A Common Stock (TXG) Financials
Key financial figures for 10x Genomics, Inc. Class A Common Stock (Q2 2026).
- Revenue
- $151M
- Net Income
- -$18M
- EPS
- $-0.14
- Total Assets
- $1.0B
- Operating Cash Flow
- $17M
Full income statement, balance sheet, and cash flow for 10x Genomics, Inc. Class A Common Stock on SentiSense.